| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5642725 | Oral Oncology | 2016 | 7 Pages |
Abstract
OSCC TGV ⩾ 1% per day is a substantive negative prognostic indicator for disease control and overall survival, particularly in HPV non-associated tumors. This novel CT-based volumetric assessment of TGV suggests a simple methodology for risk stratification of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Subha Perni, Abdallah S.R. Mohamed, Jacob Scott, Heiko Enderling, Adam S. Garden, G. Brandon Gunn, David I. Rosenthal, Clifton D. Fuller,